Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion type Assertion NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_head.
- NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_provenance.
- NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion evidence source_evidence_literature NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_provenance.
- NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion SIO_000772 7544647 NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_provenance.
- NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion wasDerivedFrom befree-2016 NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_provenance.
- NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion wasGeneratedBy ECO_0000203 NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_provenance.